Doxycycline (oral)

INCI: Doxycycline

Also known as: Doryx, Oracea

AcneactivesyntheticStrong evidenceNot for pregnancyPrescription only

Skinlumis Rating

Comedogenic

0/5

Irritancy

0/5

Best applied

Both

Effective range

Oral 40–100mg

How It Works

An oral tetracycline antibiotic. At sub-antimicrobial doses (40mg), it's used long-term for rosacea and inflammatory acne without resistance.

At antimicrobial doses, inhibits bacterial protein synthesis; at sub-microbial doses, inhibits MMPs and inflammation.

pH Range

Benefits

Reduces inflammatory acne and rosacea
Anti-inflammatory at low dose
Resistance-free at 40mg

Proven For

What the evidence supports.

RosaceaInflammatory acne

Best For

All skin types

Avoid If

Pregnant
Children under 8
Sun exposure (photosensitivity)

Layering Order

1/10

Apply early in routine, toner/essence step.

Max Safe Concentration

100mg/d

Concentration range in well-formulated products: Oral 40–100mg

Seasonal Use

Year-round; high SPF required.

Nutrition Connection

Avoid dairy/iron 2 hours either side of dose (chelation).

Skin Signals When You Need It

No specific deficiency signals tracked for this ingredient.

For Estheticians & Professionals

Oracea (40mg) is sub-antimicrobial, non-bactericidal anti-inflammatory dose.

Prescription Only

Doxycycline (oral) is a regulated medication. Use only under the guidance of a licensed physician or dermatologist. The information here is educational, Skinlumis does not dispense prescriptions or provide medical advice.

Clinical Evidence

The research behind Doxycycline (oral).

4 peer-reviewed studies

Every claim on this page traces to published research. Findings below are drawn from randomized trials and systematic reviews, each links to the study on PubMed.

Systematic Review

Gut microbiome dysbiosis is significantly associated with inflammatory skin conditions including acne and rosacea.

Dréno B, Dagnelie MA, Khammari A, Corvec S
American Journal of Clinical Dermatology, 2020

View Study →

Randomized Controlled Trial

Lactobacillus supplementation reduced acne lesion count by 48% over 12 weeks.

Bowe W, Patel NB, Logan AC
Beneficial Microbes, 2014

View Study →

Systematic Review

EPA supplementation at 1.8g/day reduced inflammatory acne lesions by 42% over 12 weeks.

Thomsen BJ, Chow EY, Sapijaszko MJ
Journal of Cutaneous Medicine and Surgery, 2020

View Study →

Systematic Review

Vitamin D deficiency significantly associated with acne vulgaris, atopic dermatitis and psoriasis.

Mostafa WZ, Hegazy RA
Journal of Advanced Research, 2015

View Study →

Pairs Well With

Topical metronidazoleAzelaic Acid

Conflicts With

No flagged conflicts. Still, patch-test new actives.

Your Skin Compatibility